Recent News

523 News Items found
Pictured: Ross Levine
Memorial Sloan Kettering researchers helped to identify a key insight into what first goes wrong in the development of many leukemias.
The Gerstner Sloan Kettering Summer Undergraduate Research Program (SURP) will welcome 25 students to this year's ten-week program.
Pictured: Ken Marians, Lorenz Studer, Greg Safko, Susan Bancroft & Yvonne Gruber
Fourth-year student Yvonne Gruber was awarded a $10,000 melanoma research grant by the Joanna M. Nicolay Melanoma Foundation.
Viviane S. Tabar
Memorial Sloan Kettering Cancer Center researchers have published new findings that may help explain why brain tumors called glioblastomas are so resistant to treatment.
Pictured: Justin Miller
Second-year student Justine Miller has received a 2011 National Science Foundation Graduate Research Fellowship Program Fellowship.
Pictured: Craig Thompson
More than 500 high school students and their teachers filled the Rockefeller Research Laboratories to learn about recent discoveries.
An interdisciplinary team from Memorial Sloan Kettering Cancer Center has shown how antibiotics can disrupt the normal, healthy balance of microorganisms in the gastrointestinal tract.
Sloan Kettering Institute Director Thomas J. Kelly
Thomas Kelly Honored
Sloan Kettering Institute Director Thomas J. Kelly is the co-recipient of the 2010 Louisa Gross Horwitz Prize from Columbia University.
Participants in Cycle for Survival
Treating Rare Cancers
Memorial Sloan Kettering physicians have experience and specialized expertise in caring for people with uncommon cancers.
Jedd Wolchok
The US Food and Drug Administration announced today that the drug ipilimumab (brand name Yervoy) has been approved for the treatment of patients with metastatic melanoma. It is the first drug ever shown to improve overall survival for patients with advanced melanoma.